Adipokines and cytokines in non-alcoholic fatty liver disease
Version of Record online: 10 DEC 2007
Alimentary Pharmacology & Therapeutics
Volume 27, Issue 5, pages 412–421, March 2008
How to Cite
JARRAR, M. H., BARANOVA, A., COLLANTES, R., RANARD, B., STEPANOVA, M., BENNETT, C., FANG, Y., ELARINY, H., GOODMAN, Z., CHANDHOKE, V. and YOUNOSSI, Z. M. (2008), Adipokines and cytokines in non-alcoholic fatty liver disease. Alimentary Pharmacology & Therapeutics, 27: 412–421. doi: 10.1111/j.1365-2036.2007.03586.x
- Issue online: 10 DEC 2007
- Version of Record online: 10 DEC 2007
- Publication data Submitted 8 November 2007 First decision 26 November 2007 Resubmitted 3 December 2007 Accepted 3 December 2007 Epub OnlineAccepted 10 December 2007
Table S1. Adipokines and pro-inflammatory cytokines in serum of morbidly obese patients with and without NAFLD: descriptive parameters and results of the group comparison by nonparametric Mann-Whitney tests. CONTROL I: morbidly obese patients with health livers. CONTROL II: healthy blood donors. SS, simple steatosis; NAFLD, non-alcoholic fatty liver disease; NASH, non-alcoholic steatohepatitis.
Please note: Blackwell Publishing are not responsible for the content or functionality of any supplementary materials supplied by the authors. Any queries (other than missing material) should be directed to the corresponding author for the article.
|APT_3586_sm_table-s1.doc||84K||Supporting info item|
|APT_table-s1.doc||84K||Supporting info item|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.